Fox Business - The Power to Prosper
Search Site

Food And Drug Administration

Intuitive Surgical Wins Jury Trial in Negligence Case

Intuitive Surgical Inc. (ISRG) prevailed in a civil lawsuit that accused it of negligence in its training of doctors using the company's surgical robot machines, a victory as it looks to counter criticisms that its da Vinci machines are unsafe and too costly.The suit, filed in Kitsap County in Washington state, had sought $8.45 million in compensatory damages in connection to the death of Fred Taylor, who had his prostate gland removed with a da Vinci robot in 2008 and died four years later. The plaintiffs alleged that complications that occurred during the surgery were the cause of Mr. Taylor's death.A jury, however, decided Intuitive hadn't been negligent in its training of the surgeons who performed Mr. Taylor's prostate removal, the culmination of a five-week trial that examined the company's training and marketing practices.Intuitive's stock price has been under pressure in recent months as investors have grown more concerned about criticism of the da Vinci's cost-effectiveness an...

Read More

  1. FDA Staff: Merck Sleep Drug Effective but Some Dosage Concerns

    Food and Drug Administration staff on Monday said a proposed sleep drug from Merck & Co. (MRK) is effective, but questioned the safety of the product's higher doses....

  2. FDA Staff: Merck Sleep Drug Effective; Safety Concerns With Higher Doses

    Food and Drug Administration staff said a proposed sleep drug from Merck & Co. (MRK) was effective, but questioned the safety of the product's higher doses.Merck is ...

  3. U.S. HOT STOCKS FUTURES: HOT STOCKS TO WATCH

    Among the companies with shares expected to actively trade in Thursday's session are Cisco Systems Inc. (CSCO), Wal-Mart Stores Inc. (WMT) and Kohl's Corp. (KSS).Cis...

  4. Pair of Studies Show Power of Immune System to Fight Cancer

    Positive results from two early-stage studies of drugs from Bristol-Myers Squibb Co. (BMY) and Roche Holding AG (RHHBY) provided fresh evidence that the power of the...

  5. FDA Approves J&J's Simponi for Ulcerative Colitis

    Johnson & Johnson's (JNJ) drug Simponi received U.S. Food and Drug Administration approval for patients with hard-to-treat cases of ulcerative colitis.The injectable...

  6. Cosmetics ingredients to watch out for

    Beware of certain beauty chemicals

  7. FDA Approves New Bayer Drug for Advanced Prostate Cancer

    Federal regulators approved a new drug Wednesday from Bayer AG (BAYN.XE, BAYRY) to treat certain types of advanced prostate cancer.The drug will be sold with the bra...

  8. FDA OKs Diagnostic Test for Roche Cancer Drug

    The U.S. Food and Drug Administration has approved a companion diagnostic test for Roche Holding AG's (RHHBY) cancer drug Tarceva, which detects certain gene mutatio...

  9. FNC Video

    FNC Video

  10. Dirty Dozen: Produce With the Highest Concentration of Pesticides

    Even if you are working hard to get the recommended amount of fruits and vegetables, you might be surprised of what exactly you're putting in your mouth.Despite stri...

  11. Ranbaxy to Pay $500 Million in Adulterated Drugs Case

    Indian generic pharmaceutical maker Ranbaxy Laboratories Ltd.'s (500359.BY) U.S. subsidiary has pled guilty to felony charges relating to adulterated drugs made at t...

  12. Ranbaxy to Pay $500 Million in Adulterated Drugs Case; Largest Such Settlement Ever

    Indian generic pharmaceutical maker Ranbaxy Laboratories Ltd.'s (500359.BY) U.S. subsidiary has pled guilty to felony charges relating to adulterated drugs made at t...

  1. Lingering tornado dangers, sunscreen guidelines, DSM debate

    Fox Health Fix: Dr. Manny reports on the top health headlines of the week

  2. Dissident Holder First Manhattan Adds Three to Vivus Board Slate

    Dissident Vivus Inc. (VVUS) shareholder First Manhattan Co. nominated three more director candidates following the drug maker's expansion of its board size.Vivus rec...

  3. Forest Labs' longtime CEO Solomon to step down at year-end

    Forest Laboratories Inc said Howard Solomon, its chief executive of more than 35 years, will retire at the end of this year, capping a tenure that saw the company mo...

  4. U.S. Slaps Ban on Another Indian Drugmaker

    The U.S. Food and Drug Administration slapped an import ban on Indian drugmaker Wockhardt Ltd. (532300.BY) after one of the company's plants failed an FDA safety ins...

  5. Dissident Holder First Manhattan Adds 3 to Vivus Board Slate

    Dissident Vivus Inc. (VVUS) shareholder First Manhattan Co. nominated three more director candidates following the drug maker's expansion of its board size.Vivus rec...

  6. Gilead Hepatitis C Drug Gets Accelerated Review

    Gilead Sciences Inc. (GILD) said the marketing authorization application for its new hepatitis C drug has been validated by the European Medicines Agency and granted...

  7. Medtronic Sales Rise 4% As Heart, Spinal Sales Rebound

    Medtronic Inc.'s (MDT) fiscal fourth-quarter sales grew roughly 4%, but expenses related to employee layoffs and manufacturing consolidation caused earnings to fall ...

‹ Prev12345Next ›
Freebase CC-BY
Source: Food And Drug Administration on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL